mw151
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2020 (NCT04120233)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05417282 | Phase 1 | Jul 1, 2022 | ImmunoChem Therapeutics, LLC, National Cancer Institute (NCI), Northwestern University |
| NCT04120233 | Phase 1 | Jan 31, 2020 | Duke University, ImmunoChem Therapeutics, LLC, National Institute on Aging (NIA), University of Kentucky |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ImmunoChem Therapeutics, LLC | For profit | 2 | 1 | 1 | 2020 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2022 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2020 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Kentucky | Academic/Hospital | 1 | 1 | 1 | 2020 |
6 organizations
Page 1 / 1